UIH Technologies recalled two units of the uEXPLORER MD system on September 12, 2025. Third-party covers can trap between the patient table and gantry, causing mechanical interference. Healthcare providers must stop using the device immediately and follow recall instructions.
Third-party outer covers can become trapped between patient table and gantry, causing mechanical interference during table movement.
Patients and healthcare providers should stop using this device immediately. Follow the recall instructions provided by the manufacturer. Contact UIH Technologies LLC or your healthcare provider for instructions. Notification method: Letter
The recalled units include the uEXPLORER MD model with UDI: (01)06971576832040, Serial Number: F00002, and F00015. The devices were distributed in the U.S. and internationally.
The third-party outer covers can become trapped, leading to mechanical interference during table movement. This poses a high risk to patient safety and could result in injury.
There are no reported injuries or incidents associated with this recall. However, the potential for mechanical interference poses a significant risk.
Immediately stop using the uEXPLORER MD system. Contact UIH Technologies LLC or your healthcare provider for further instructions.
For more information, visit UIH Technologies' website or call their customer service number. Recall instructions are also provided in a notification letter.
Get notified about recalls in categories you care about.
Bristol-Myers Squibb recalled 12,778 vials of Opdualag injection on October 21, 2025. The recall stems from a lack of assurance of sterility. The affected products were distributed nationwide in the United States.
Major Pharmaceuticals recalled Gabapentin Capsules, USP, 100 mg, on October 10, 2025, due to failed impurities specifications. The recall affects several lot numbers distributed nationwide. Consumers must stop using the affected capsules immediately.
Lannett Company, Inc. recalled 46,848 bottles of Niacin Extended-release Tablets on October 10, 2025. The recall follows reports of failed dissolution specifications, which could affect medication effectiveness. Consumers should stop using the product immediately and consult healthcare providers for guidance.